Shares of Shiseido Co. (OTCMKTS:SSDOY – Get Free Report) gapped down prior to trading on Tuesday. The stock had previously closed at $23.66, but opened at $22.81. Shiseido shares last traded at $22.81, with a volume of 748 shares changing hands.
Shiseido Price Performance
The company has a quick ratio of 0.94, a current ratio of 1.38 and a debt-to-equity ratio of 0.37. The business’s 50-day moving average is $22.18 and its two-hundred day moving average is $19.60. The company has a market capitalization of $9.43 billion, a P/E ratio of -59.03, a price-to-earnings-growth ratio of 0.94 and a beta of 0.27.
Shiseido (OTCMKTS:SSDOY – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.12. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. Shiseido had a negative net margin of 2.39% and a positive return on equity of 4.06%. Shiseido has set its FY 2026 guidance at 0.670-0.670 EPS. As a group, analysts predict that Shiseido Co. will post 0.80 earnings per share for the current year.
About Shiseido
Shiseido Company, Limited is a Japanese beauty and cosmetics company headquartered in Tokyo. Founded in 1872 by Arinobu Fukuhara as a Western-style pharmacy in Ginza, Tokyo, the company has grown into an international beauty group serving consumers through retail, e-commerce and professional channels.
Shiseido develops, manufactures and sells skincare, makeup, fragrances, hair-care products and other beauty-related offerings. Its portfolio includes the Shiseido brand as well as prestige and specialty brands such as Clé de Peau Beauté, NARS, Drunk Elephant, IPSA, bareMinerals and Laura Mercier.
Featured Articles
- Five stocks we like better than Shiseido
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
Receive News & Ratings for Shiseido Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shiseido and related companies with MarketBeat.com's FREE daily email newsletter.
